LBX Pharmacy Chain JSC
SSE:603883
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
LBX Pharmacy Chain JSC
SSE:603883
|
11.6B CNY |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.5B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.3B ZAR |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45.2B BRL |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.7B CNY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
640.3B JPY |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
LBX Pharmacy Chain JSC
Glance View
LBX Pharmacy Chain JSC has emerged as a significant player in the pharmaceutical retail sector in China, riding the wave of increasing health consciousness and the aging population. Founded in a fast-paced, constantly evolving market, the company has strategically positioned itself to leverage this demographic shift. Its primary business model revolves around operating an extensive network of pharmacy outlets that serve both urban and rural customers. By offering a wide range of products, from prescription medications to health supplements and wellness goods, LBX ensures it caters to a diverse clientele, satisfying varying health care needs. The implementation of an omnichannel approach, integrating online and offline sales, has not only enhanced customer convenience but also expanded its reach, reinforcing its market position. Central to LBX’s profitability is its efficient supply chain management and strategic location of stores in high-traffic areas, which augments its accessibility and stock management capabilities. The company leverages partnerships with leading pharmaceutical manufacturers and distributors, securing competitive pricing and product availability. Additionally, its investment in technology bolsters its operational efficiency, enabling real-time inventory tracking and personalized customer service. This tech-driven approach enhances customer loyalty and provides insights into consumer behavior, guiding strategic decisions. Through a well-crafted blend of traditional retail expertise and innovative solutions, LBX Pharmacy Chain JSC continues to solidify its foothold in the market, driving revenue growth and expanding its reach across China.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for LBX Pharmacy Chain JSC is 1.9%, which is below its 3-year median of 3.3%.
Over the last 3 years, LBX Pharmacy Chain JSC’s Net Margin has decreased from 4.1% to 1.9%. During this period, it reached a low of 1.9% on Jun 30, 2025 and a high of 4.3% on Mar 31, 2024.